Economic Evaluation of NHS England’s Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling
- DOI
- 10.1007/s41669-025-00622-x
- Published
- 2025-12-18
- Container
- PharmacoEconomics - Open
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s41669-025-00622-x,
title = {Economic Evaluation of NHS England’s Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling},
author = {Adam Martin and Tayamika Zabula and Davide Tebaldi and Miaoqing Yang and Tamara Brown and Louisa Ells},
year = {2025},
journal = {PharmacoEconomics - Open},
doi = {10.1007/s41669-025-00622-x},
url = {https://doi.org/10.1007/s41669-025-00622-x}
}RIS
TY - JOUR TI - Economic Evaluation of NHS England’s Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling AU - Adam Martin AU - Tayamika Zabula AU - Davide Tebaldi AU - Miaoqing Yang AU - Tamara Brown AU - Louisa Ells PY - 2025 JO - PharmacoEconomics - Open DO - 10.1007/s41669-025-00622-x UR - https://doi.org/10.1007/s41669-025-00622-x ER -
APA
Martin, A., Zabula, T., Tebaldi, D., Yang, M., Brown, T., & Ells, L. (2025). Economic Evaluation of NHS England’s Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation Modelling. PharmacoEconomics - Open. https://doi.org/10.1007/s41669-025-00622-x
Source records
- crossref · retrieved 2026-09-26T22:38:32.947Z